| 摘要 |
Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification. The compounds can be prepared from compounds of formulae (Ia) and (V) by methods described herein. The compounds of formula (I) are FAAH enzyme inhibitors useful in the treatment of acute or chronic pain, dizziness, vomiting, nausea, eating disorders, neurological and psychiatric pathologies, acute or chronic neurodegenerative diseases, epilepsy, sleep disorders, cardiovascular diseases, renal ischaemia, cancers, disorders of the immune system, allergic diseases, parasitic, viral or bacterial infectious diseases, inflammatory diseases, osteoporosis, ocular conditions, pulmonary conditions, gastrointestinal diseases or urinary incontinence.
|
